Nukkleus Inc. 8-K/A Report: Important Corrections & Financial Insights

Here's the extracted key information and insights from the provided financial report section:

Company Information:

• Entity Name: Nukkleus Inc.
• CIK: 0001787518
• Incorporation State: Delaware (DE)
• SEC Reporting Number: 001-39341
• Tax ID: 38-3912845
• Address: 525 Washington Blvd, Jersey City, NJ 07310
• Phone Number: 212-791-4663

Filing Details:

• Form Type: 8-K/A (Amended Current Report)
• Filing Date: January 7, 2025
• Original Filing Date: January 8, 2025
• Correction Purpose: The amendment is made to correct the item under which the form was originally filed. It now correctly states that it is under "Item 8.01 Other Events" instead of "Item 4.02 Non-Reliance on Previously Issued Financial Statements."

Financial Instruments:

• Common Stock:
• Par Value: $0.0001 per share
• Ticker Symbol: NUKK
• Exchange: NASDAQ
• Warrants:
• Description: Each warrant is exercisable for one share of common stock at a price of $92.00 per share.
• Ticker Symbol: NUKKW
• Exchange: NASDAQ

Context and Financial Statements:

• Reporting Period: The information pertains to a specific date, January 7, 2025.
• Correction Clarification: The company indicates that it has not concluded that its previously issued unaudited condensed financial statements cannot be relied upon, which is crucial for stakeholders assessing the reliability of the financial data.

Summary:

The filing serves to amend a previous 8-K report, providing clarity on the nature of the report and correcting the item classification. Nukkleus Inc. is engaged in trading common stock and warrants, with specific details on their value and exercise conditions. Stakeholders should note the company's assurance regarding the reliability of prior financial statements as it may affect investor confidence and decision-making.